Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 17 (MTND6P17) is a nuclear-encoded sequence annotated as a pseudogene related to the mitochondrial gene MT-ND6 (NADH:ubiquinone oxidoreductase core subunit 6). Unlike the true mitochondrial MT-ND6 gene—which encodes a protein subunit of mitochondrial Complex I and is implicated in diseases such as Leber hereditary optic neuropathy and Leigh syndrome—this pseudogene does not produce a functional protein. Pseudogenes generally result from duplication or reverse transcription events and typically lack the regulatory and coding sequences necessary for gene expression. There is no evidence that MTND6P17 is functionally transcribed or translated, nor does it play a direct role in biological pathways, disease, or as a therapeutic target[1][2][3][4].\n\nIf you require information about the functional and disease relevance of the bona fide mitochondrial gene MT-ND6, let me know.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 17 (MTND6P17).